ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

View by Title View by Number View Themes
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: PB1671

    C-type Lectin-like Proteins D and E, but Not Botrocetin, Cause Thrombocytopenia during Bothrops jararaca Snakebite Envenomation

    A.T.A. Sachetto1,2, M.E. Peichoto3, J.G. Rosa1,2, R.J.S. Torquato4, D.T. Silva5, S.M.T. Serrano5, A.S. Tanaka4, M.L. Santoro1,2

  • Abstract Number: PB1990

    Ca2+ Release from Stores Controlled by Sarco/Endoplamic Reticulum Ca2+-ATPase 3 (SERCA3) Is Involved in Endothelial Permeability and Inflammatory Response

    K. Beddek, F. Adam, F. Saller, D. Borgel, C. Denis, R. Bobe

  • Abstract Number: PB0659

    Calibrated Automated Thrombogram II: A New Thrombin Generation Test

    P.L.A. Giesen1, A. Gulpen2, R. van Oerle2, H. ten Cate2, M. Nagy2, H.M. Spronk2

  • Abstract Number: PB2359

    Can an Effective anticoagulation Clinic Reduce Bleeding Risks?

    A. Al-Hassani1, B. Packham1, K.M. Ang2, R. Patel3

  • Abstract Number: PB0610

    Can Bone Marrow Cells Be Differentiated and Counted Using a Novel Hematology Analyzer?

    Z. Kaya1, S. Kirkiz1, L. Aydin Kaynar2, Z.N. Özkurt2, Ü. Koçak1, M. Yağci2

  • Abstract Number: PB1315

    Can we Predict the Clinical Course of Children with ITP by MPV? A Preliminary Study

    Y. Lee1, H. Yoon1, S. Cho2

  • Abstract Number: PB1334

    Can we Predict the Outcome of Splenectomy for Primary Immune Thrombocytopenia? Conclusion Based on Systematic Review and Meta-Analysis

    M. Mitrovic1,2, D. Antic1,2, N. Milic3, M. Virijevic1,2, Z. Pravdic1, N. Sabljic1, N. Pantic1, N. Suvajdzic Vukovic1,2

  • Abstract Number: PB1232

    Canadian Guidelines Regarding Safe Blood-draw Volumes for Research in Pediatric Participants

    K. Hamilton1, A.K. Chan2, M. Bhatt2

  • Abstract Number: PB2179

    Cancer Associated Thrombosis: Are DOACs a Treatment Option? Systematic Review and Meta-analysis of Randomised Controlled Trials

    R. Alikhan, M. Rees

  • Abstract Number: PB2173

    Cancer Patients Has Lower Plasmin Generation by Simultaneous Thrombin and Plasmin Assay Evaluation

    G. da Silva Souza Gois, M. Evelyn Alves de Almeida, T. Ramires Rodrigues Alencar, S. Aparecida de Lima Montalvão, B. Moraes Martinelli, I. Macedo Toni, J. Barreto Carvalheira, N. Adami Andreollo, M. Etchebehere, J. Cesar Teixeira, J. Maria Annichino-Bizzacchi, ADVENTH Cancer Investigators

  • Abstract Number: PB2177

    Cancer Site and Distant Metastasis at Diagnosis Predict the Risk of VTE in Cancer

    S.K. Braekkan1, M.E. Gabrielsen2, B. Brumpton2, K. Hveem2, J.-B. Hansen1

  • Abstract Number: PB0439

    Canonical Signaling Pathways Dysfunctions in the Development of Major Cardiovascular Complications, Circulating Micrornas as Novel Biomarkers and their Link to Inflammation in Diabetic Patients

    C. Eyileten1, J. Pordzik1, A. Soplinska1, J. Jarosz-Popek1, P. Czajka1, Z. Wicik1,2, M. Wolska1, W.-L. Liu1, S. De Rosa3, D. Mirowska-Guzel1, M. Postula1

  • Abstract Number: PB1863

    Caplacizumab in a Case of Acquired Thrombotic Thrombcytopenic Purpura (TTP) Poor Responsive to Plasma Exchange and Immunosuppressive Therapy

    A. Molteni, C. Dellanoce, A. Pasini, O. Paoletti, A. Mancini, V. Cancelli, M. Tajana, M. Tala, S. Belletti, R. Morandini, C. Fiamenghi, P. Spedini, S. Testa

  • Abstract Number: PB0737

    Carboxypeptidase U (CPU, TAFIa, CPB2) Generation in Acute Ischemic Stroke Patients Undergoing Thrombolysis and Endovascular Thrombectomy

    J.C. Mertens1, V. Blanc-Guillemaud2, K. Claesen1, D. Leenaerts1, B. Tyl2, P. Cardona3, D. Hendriks1, C.A. Molina4,5

  • Abstract Number: PB0137

    Cardiac Myosin Promotes Thrombin Generation and Coagulation in vitro and in vivo

    M. Shukla1, H. Deguchi1, J. Zilberman-Rudenko1,2, Y. Oyama3, T. Eckle3, Z. Guo1, S. Lear1, W. Shen1, T. Wyseure1, L. Mosnier1, J. Orje1, Z. Ruggeri1, O. McCarty2, J. Griffin1

  • Abstract Number: PB0934

    Cardiovascular Risk Factor Profile among North-Eastern Brazilian Adults with Haemophilia

    R.M. Camelo1,2,3, B.P. Duarte2, M.C.B. Moura2, N.C.M. Costa2, I.M. Costa2, C.G.P. Roncal2, A.M. Vanderlei2, T.M.R. Guimaraes2, C. Caram-Deelder3, S.C. Gouw3, S.M. Rezende1, J.G. van der Bom3,4

  • Abstract Number: PB0071

    Cardiovascular Risk in Systemic Lupus Erythematosus

    M. Kechida1, A. Fraj1, S. Daada1, R. Klii1, S. Hammami1, M. Sassi2, I. Khochtali1

  • Abstract Number: PB2194

    Carrier Frequencies of Antithrombin-, Protein C-, or Protein S-deficient Variants Estimated Using a Public Database and Expression Experiments

    K. Maruyama, K. Kokame

  • Abstract Number: PB1923

    Catastrophic Antiphospholipid Syndrome, Kikuchi-Fujimoto Disease and Adult-Onset Still Disease: An Unusual Association

    S.D.A. Peres1, G. Remondino2, F. Aranda1, A. Lucero1, G. Lencinas1, E. Cunto1, G.F. de Larrañaga1

  • Abstract Number: PB2342

    Catheter-associated Thrombosis at the Hematology Center: Analysis of 2212 Medical Records from a Developing Country

    L. Hambardzumyan1,2, H. Grigoryan1,3, L. Mkrtchyan2, M. Badikyan2,4, S. Danielyan2, G. Tamamyan1,5, N. Sargsyan6, L. Petrosyan6, L. Sahakyan2, H. Khachatryan6

  • Abstract Number: PB2143

    Catheter-Associated Upper Extremities Deep Vein Thrombosis in Cancer Patients: Does Anticoagulation Time Matter?

    A. Dalla Salda, E. Spaggiari, B. Abbate, M. Iotti, L. Depietri, S. Corradini, I. Lambertini, M.R. Veropalumbo, A. Ghirarduzzi

  • Abstract Number: PB1346

    CD4+ T Cell Expression of IL-10 Compared to IL-17 is Lower in Patients with Immune Thrombocytopenia (ITP) Who Do Not Respond Clinically to High Dose Corticosteroid

    M. Stimpson1, P. Lait1, L. Schewitz-Bowers1, E. Williams1, R. Lee1,2, C. Bradbury2,3

  • Abstract Number: OC 04.3

    CD84 Links T Cell and Platelet Activity in Cerebral Thrombo-inflammation in Acute Stroke

    D. Stegner1, M.K. Schuhmann2, G. Stoll2, M. Bieber2, T. Vögtle1, S. Hofmann1, M. Seyhan3, A.M. Kollikowski4, V. Klaus1, P. Heuschmann3, M. Pham4, B. Nieswandt1

  • Abstract Number: PB2001

    Cell-free DNA and Citrullinated Histone H3 Plasma Levels Improve the Prediction of Mortality in Septic Patients

    M. Moiana, E. Cunto, C. Dominguez, V. Chediack, S. Perés, G. de Larrañaga

  • Abstract Number: PB0445

    Cell-free DNA Is Elevated in Chronic Myeloproliferative Neoplasms: Correlation with Thrombosis and Disease Progression

    G. De Luca1, C.P. Marin Oyazún1, A.C. Glembotsky1, M. Gutierrez2, M. Castro Rios3, B. Moiraghi4, A. Vicente5, F. Sackmann6, G. Bendek7, A. Varela4, V. Cortes Guerrieri8, V. Verri8, V. Caula8, V. Vallejos9, P.R. Lev1, N.P. Goette10, D. Ayala1, R.F. Marta1, M. Schattner11, P.G. Heller1

  • Abstract Number: PB0722

    Cellular Factor XIII Externalization in Platelets and Platelet Microparticles Induced by Receptor Mediated and Non-Receptor Mediated Platelet Activation

    L. Somodi1, I. Beke Debreceni2, H. Bárdos3, Á. Bana3, J. Kappelmayer2, L. Muszbek1

  • Abstract Number: PB2163

    Cerebral Sinus Venous Thrombosis in Children with Leukemia: Single-institution Report

    I. Melnichenko1,2, L. Krmoyan1,2, H. Khachatryan3, A. Zakharyan2,4, N. Martirosyan2, S. Hovhannisyan2, M. Gizhlaryan1,2, S. Danielyan5, G. Tamamyan1,2, L. Vagharshakyan1,2

  • Abstract Number: PB2468

    Cerebral Vein Thrombosis Treatment with Direct Oral Anticoagulants: A Case Series

    S. Barbar1, F. Boscaro2, E. De Bon1, A. Bozzolin2, L. Scarano1, F. Fabris2, M.T. Sartori2

  • Abstract Number: PB0583

    Challenges in Anticoagulation Management at an Academic Medical Center, 20 Years of Clinical Observations

    S. Kogan

  • Abstract Number: PB1250

    Challenges in Diagnosing and Treating Polycythemia Vera with Acquired von Willebrand Disease in a Pediatric Patient

    J. Jain, A. Tang, C. Bennett

  • Abstract Number: PB0749

    Changes in Fibrinolytic Factors in a Simulated Extracorporeal Membrane Oxygenator Circuit

    A. Doyle1, N. Gooby2, K. Parmar1, K.A. Breen2, N.A. Barrett2, A. Retter2, B.J. Hunt1

  • Abstract Number: PB0063

    Changes in the Hemostasis System in Athletes

    N. Vorobyeva1, N. Malishkina2

  • Abstract Number: PB0015

    Changes of Soluble Fibrin-Monomer Complex Concentration in Different Types of Coronary Artery Disease

    Y. Tyravska1, V. Lizogub1, D. Pliskevych2, T. Vovk3, O. Savchuk3

  • Abstract Number: PB0206

    Characterisation and Evaluation of a Candidate Bethesda Assay Reference Reagent Developed from Recombinant, Patient-Derived FVIII Inhibitors

    C. Coxon1, J. Beavis2, X. Yu3, S. Diamond3, A. Riches1, S. Raut1

  • Abstract Number: PB2187

    Characterisation of a Novel F5 Gene Mutation (Ala2114Asp, Factor V Besançon) Associated with Factor V Deficiency and Recurrent Venous Thrombosis

    E. Castoldi1, N. Hézard2, G. Mourey3, K. Wichapong1, M. Ibrahim-Kosta4, M.C.L.G.D. Thomassen1, A. Fournel3, M.-C. Alessi4, T.M. Hackeng1, J. Rosing1, P.-E. Morange4

  • Abstract Number: PB2240

    Characterisation of Antithrombin p.Thr147Ala, the First Common Founder Variant from African Origin Responsible for Inherited Antithrombin Deficiency

    B. de la Morena-Barrio1, J. Padilla2, I. Pareyn3, C. Bravo-Pérez2, K. Vanhoorelbeke3, I. Martínez-Martínez2, V. Vicente2, J. Corral2, K. Jochmans4, M.E. de la Morena-Barrio2, C. Orlando4

  • Abstract Number: PB0376

    Characterisation of Plasma Microvesicles in Type 2 Diabetes mellitus Patients with and without Microalbuminuria

    A. Vaidya1, K. Gooding1, A. Shore1, G. Pula1,2

  • Abstract Number: PB2340

    Characterising the Burden of Hospital-acquired Venous Thromboembolism Arising during Admission and Following Discharge in an Irish Hospital Group Serving a Population of over One Million Individuals

    K. Ewins1,2, M. Day3, M. Fitzpatrick3, N. Bannon3, T. Breslin2,4, K. Murphy2,5, S.W. Maung2,3,6, A.-M. O'Neill7, F. Ni Ainle1,2,8, B. Kevane1,2,3

  • Abstract Number: PB1374

    Characteristics and Outcome of Patients with Thrombocytopenia Secondary to Acute Cytomegalovirus Infection: Case Series and Literature Review

    T. Shragai1, E. Lebel2, D. Deshet3, D. Varon1,2, I. Avivi1,4, I. Kirgner1, N. Sarid1

  • Abstract Number: PB0107

    Characteristics and Recurrence of Acute Ischemic Stroke in Children: An Examination Using Real World Data

    J. Hardin1,2, L. Wang3, Z. Yuan3, H. Patino4, J. Weaver1,2

  • Abstract Number: PB1319

    Characteristics of Patients with Cyclic Thrombocytopenia: An Observational Cohort Study

    O. Steinbrecher1, L. Eischer1, H. Sinkovec2, M. Mitrovic3, S. Eichinger1, P.A. Kyrle1

  • Abstract Number: PB0101

    Characterization and Antithrombotic Treatment of Patients with Acute Ischemic Stroke and No Atrial Fibrillation: A Real-world Study

    L. Wang, J. Weaver, J. Hardin, E. Barnathan, J. Foody, G. Peters, Z. Yuan

  • Abstract Number: PB1195

    Characterization and Management of Patients with Mild or Moderate Hereditary Factor X Deficiency: A Retrospective Chart Review

    S. Acharya1, C. Sabo2, M. Chitlur3

  • Abstract Number: PB1155

    Characterization of Factor IX-FIAV: A Factor IX Variant that Displays Cofactor-Independent Activity

    V.J.F. Strijbis1, K.L. Cheung1, P. Konstantinova2, Y.P. Liu2, S. van Deventer2, M.H.A. Bos1

  • Abstract Number: PB1413

    Characterization of Murine Monoclonal Anti-PF4/Polyanion Antibodies, as Potential Useful Tools for Studies on Typical and Autoimmune HIT

    C. Vayne1,2, T.-H. Nguyen3,4, J. Rollin1,2, N. Charuel1, A. Poupon5,6, C. Pouplard1,2, Y. Gruel1,2, A. Greinacher3

  • Abstract Number: PB1159

    Characterization of Neutralizing Anti-emicizumab Antibody Developed in a Hemophilia A Patient

    C. Valsecchi1, M. Gobbi2, L. Schiavone1, M. Beeg2, T.E. Adams3, M.E. Mancuso1, J.A. Huntington3, F. Peyvandi1,4

  • Abstract Number: PB1644

    Characterization of the Hypercoagulable State and NETosis in Systemic Lupus Erythematosus

    E. Monzón Manzano1, I. Fernández Bello1, Á. Robles Marhuenda2, R. Justo Sanz1, P. Acuña Butta1, F.J. López Longo3, M.T. Álvarez Román1, V. Jiménez Yuste1, N. Butta Coll1

  • Abstract Number: OC 08.5

    Characterization of the Protein Profile in Thrombi of Patients with Ischemic Stroke and Identification of Potential Biomarkers as Predictors of Negative Clinical Evolution

    C. Lopez-Pedrera1, A. Ibañez-Costa1, C. Perez-Sanchez1, M. Luque-Tevar1, A.M. Patiño-Trives1, M.D.C. Abalos-Aguilera1, N. Barbarroja1, J.J. Ochoa-Sepulveda2, F. Delgado-Acosta2, R. Oteros-Fernandez2, F. Velasco3

  • Abstract Number: PB1699

    Characterization of Thrombus Heterogeneity and Dynamics of Formation on Collagen Spots in a Parallel-plate Flow Chamber

    A. Ryabykh1, E. Beresneva2,3, D. Nechipurenko1,2,3, M. Panteleev1,2,3

  • Abstract Number: PB1548

    Characterization of Type 2B VWD in the US Zimmerman Program

    P. Christopherson, V. Flood, S. Haberichter, T. Slobodianuk, P. Morateck, R. Montgomery, Zimmerman Program Investigators

  • Abstract Number: PB2049

    Characterization of VKA Control in Patients with Thrombotic and Major Hemorrhagic Events in Anticoagulation Hematology Units: Results from the EVENTHO Study

    O. Gavín1, V. Roldán2, A. Santamaría3, P. Llamas4, D. Arumí5, S. Fernández de Cabo5

  • Abstract Number: PB1659

    Characterizing Platelet Granules of von Willebrand Disease Patients Using Super-Resolution Structured Illumination Microscopy

    M. Swinkels1, J.A. Slotman2, F.W.G. Leebeek1, J. Voorberg3, R. Bierings1, A.J.G. Jansen1,3

  • Abstract Number: OC 02.2

    Chemical Modulation of Fibrinogen Production and its Impact on Venous Thrombosis

    R. Vilar1, S.W. Lukowski2, M. Garieri1, C. Di Sanza1, M. Neerman-Arbez1,3, R.J. Fish1

  • Abstract Number: PB1807

    Chemotherapy – Induced Thrombocytopenia in Pediatric Acute Lymphoblastic Leukemia: A Single-institution Report

    M. Gizhlaryan1,2, L. Sahakyan3, L. Krmoyan1,2, M. Petrosyan1,2, I. Melnichenko1,2, M. Anastasiadi1,2, H. Danelyan1,2, S. Danielyan3, G. Tamamyan1,2, L. Vagharshakyan1,2

  • Abstract Number: PB1236

    Chronic Refractory Immune Thrombocytopenia is Associated with a High Frequency of Potentially Damaging Variants in Immune Genes

    S. Zhao

  • Abstract Number: PB1769

    Chronically Elevated Interleukin-6 Levels in Mice Lead to a Disturbance in the Coagulation System

    T. Knopp1,2, J. Lagrange1,3, R. Schüler1,4, F. Ridder1,4, J. Wild1,2, H. Rossmann5, H.M.H. Spronk6, T. Münzel2, B. Lämmle1,7,8, W. Ruf1, P. Wenzel1,2, A. Waisman4, S. Karbach1,2

  • Abstract Number: PB0465

    Circulating MicroRNA Levels Indicate Platelet Activation in Endotoxemia Despite Platelet P2Y12 Inhibition

    A. Braza Boils*1,2, T. Barwari*1, C. Gutmann*1, M.R. Thomas3, H.M. Judge4, A. Joshi1, R. Pechlaner5, S. Skalicky6, M. Hackl6, M. Shankar-Hari7, R.A. Ajjan8, I. Sabroe4, R.F. Storey4, M. Mayr1, These three authors contributed equally to this work

  • Abstract Number: PB0437

    Circulating MicroRNAs and Platelet Extracellular Vesicles as Novel Biomarkers in Acute Ischaemic Stroke

    C. Eyileten1, P. Czajka1, D. Jakubik2, J. Jarosz-Popek1, Z. Fitas1, A. Nowak1, L. Zareba1, G. von Baumgarten1, S. De Rosa3, A. Gasecka4, M. Wolska2, L. Sharif2, D. Mirowska-Guzel1, A. Czlonkowska5, M. Postula1

  • Abstract Number: PB1404

    Circulating Myeloid-related Protein (MRP)-8/14 May Contribute to Suboptimal Response to Low Dose Aspirin in Patients with Type 2 Diabetes mellitus

    P.G.M. Simeone, R. Tripaldi, R. Liani, S. Ciotti, A. Boccatonda, D. D'Ardes, F. Santilli

  • Abstract Number: PB0209

    Circulating T Helper 17 Cells (Th17) Increase at a Higher Rate than Tregs in Previously Untreated Patients with Severe Hemophilia A Who Develop Inhibitors During the First 50 Exposure Days to rFVIII

    D. Brown1, V. Berg2, J. Blatny3, K. Fijnvandraat4, J. Klintman5, C. Male6, C. McGuinn7, S. Meeks8, E. Mullins9, V. Radelescu10, M. Ragni11, M. Recht12, E. Santagostino13, A. Shapiro14, J. Staber15, H. Yaish16, P. LeBeau17, J. Bowen17, B. Gangadharan18, B. Reipert18

  • Abstract Number: PB1932

    CliA Immunoassay: Better Identification of High Thrombotic Risk Triple Positive Antiphospholipid Patients

    B. Montaruli1, A. Romito1, C. Guiotto1, T. Bertero2, P. Sivera3, D. Cosseddu1

  • Abstract Number: PB1867

    Clinical Analysis of 83 Patients with Thrombotic Thrombocytopenic Purpura

    W. Xiyan, L. Xiaofan, X. Feng, L. Wei, C. Yunfei, H. Yueting, F. Rongfeng, Z. Lei, Y. Renchi

  • Abstract Number: PB/CO02

    Clinical and Computed Tomography Characteristics of COVID-19 Associated Acute Pulmonary Embolism: A Different Phenotype of Thrombotic Disease?

    L.F. van Dam1, L.J.M. Kroft2, L.I. van der Wal3, S.C. Cannegieter4, J. Eikenboom1, E. de Jonge3, M.V. Huisman1, F.A. Klok1

  • Abstract Number: PB1889

    Clinical and Economic Impacts of a New Rapid ADAMTS-13 Assay for the Diagnosis of Suspected Thrombotic Thrombocytopenic Purpura

    C. Novelli1, B. Montaruli2, L. Solfietti3, A. Valpreda4, M. Bazzan3, B. Basolo3, I.L.A. Beverina1, M. Milan5, B. Brando1

  • Abstract Number: PB2186

    Clinical and Laboratory Characteristics of Patients with Hereditary Thrombophilias in the North-Western Region of Russia

    O. Soldatenkova1,2, V. Soldatenkov1, L. Papayan1, S. Kapustin1, N. Gordeev2, N. Mineeva1, A. Chechetkin1, K. Komissarov1

  • Abstract Number: PB1340

    Clinical and Laboratory Factors Affecting Chronicity in Children Diagnosed with Immune Thrombocytopenia

    Y. Ay1, H. Sarbay2

  • Abstract Number: PB1495

    Clinical and Molecular Characterization of Chinese Patients with Wiskott-Aldrich Syndrome

    X. Zhang1, D. Zhang2, R. Yang2, F. Zhou1

  • Abstract Number: PB1561

    Clinical and Phenotypic Evaluation of Patients with Low von Willebrand Factor

    O. Seidi Zadeh, M. Ahmadinejad, M. Mojtabavi, S. Homayoun

  • Abstract Number: PB1304

    Clinical and Radiological Outcome in a Single Center Cohort of Pediatric Patients with Focal Cerebral Arteriopathy (FCA). Safety of Antithrombotic Prophylaxis and Therapy

    A. Beccaria1, E.J. Svahn2, M. Bertamino3, M. Severino4, A. Pistorio5, L. Banov2, A.C. Molinari2

  • Abstract Number: PB2040

    Clinical Case: Reversal of Dabigatran Levels in Patients with Renal Insufficiency that Have Required the use of Idarucizumab

    A. Tugues Peiró1, C. Marzo Alonzo1, E. Vicente Pascual1, A. Ferrero Campos1, A. Ruiz1, M.E. Rivero1, A. Garcia Guiñon1, A. Luaña1, C. Chavez1, M. Teixido1, X. Gomez2, T. Garcia1

  • Abstract Number: PB2448

    Clinical Characteristics and Outcomes of Non-cancer, Non-CVC Associated upper Extremity DVT

    O. Cohen1, L. Bertú1, E. Antonucci2, G. Palareti2, W. Ageno1

  • Abstract Number: PB1171

    Clinical Characteristics of Patients with Rare Bleeding Disorders: Real-Life Data from the Netherlands (RBiN Study)

    J.L. Saes1,2, M.J.A. Verhagen1,2, K. Meijer3, M.H. Cnossen4, R.E.G. Schutgens5, M. Peters6, L. Nieuwenhuizen2,7, F.J.M. van der Meer8, I.C. Kruis9, W.L. van Heerde2,10,11, S.E.M. Schols1,2, RBiN Study Group

  • Abstract Number: PB0613

    Clinical Exomes for the Diagnosis of Inherited Bleeding, Thrombotic and Platelet Disorders: The Belgian Experience

    C. Van Laer1,2, M. Jacquemin1,2, C. Thys1, E. Van Hoof3, A. Corveleyn3, K. Peerlinck1,4, K. Freson1

  • Abstract Number: PB1094

    Clinical Immunogenicity of Valoctocogene Roxaparvovec in GENEr8-1, a Phase 3 Study of AAV5-Mediated Gene Therapy Encoding Human FVIII for the Treatment of Hemophilia A

    B. Long, C. Vettermann, A. Lawal, B. Kim, W.Y. Wong, G. Hayes, T. Seitel, K. Lau, K. Sandza, K. Patton, X. Yang, B. Schweighardt

  • Abstract Number: PB0077

    Clinical Implications of White Blood Cell Count and Platelet Indices in Individuals with Risk Factor of Coronary Artery Disease

    S. Lasom1, K. Chainam2

  • Abstract Number: PB1080

    Clinical Improvement of Haemophilic Arthropathy in a Female Pediatric Patient with Severe Hemophilia A Following Treatment with Emicizumab

    F. Xavier1,2, C. McShea2, J. Squires1, S. Tadros1, M. Ragni3,4

  • Abstract Number: PB2352

    Clinical Indications and Efficacy of Low Molecular Weight Heparin (LMWH) in Pregnancy

    R. Akbar1, M. Javed2

  • Abstract Number: PB2102

    Clinical Outcome of Anticoagulation for Acute Venous Thromboembolism Associated with Different Types of Cancer

    W. Wysokinski1, D.T. Vlazny1, R.D. McBane1, D.O. Hodge2, D.A. Froehling1, D.E. Houghton1, L.G. Peterson1, A.I. Casanegra1

  • Abstract Number: PB2146

    Clinical Outcome of Splanchnic and Usual Site Venous Thrombosis in Patients with Solid Cancer

    E. Valeriani1, M. Di Nisio2, N. Riva3, L.M. Caiano4, E. Porreca1, S.M. Bang5, J. Beyer-Westendorf6, M.T. Sartori7, G. Barillari8, R.C. Santoro9, R. Duce10, P. Kamphuisen11, A. Alatri12, A. Malato13, G. Vidili14, D. Oh15, S. Schulman16, W. Ageno4, International Registry on Splanchnic Vein Thrombosis (IRSVT) Study Group

  • Abstract Number: PB0288

    Clinical Outcome of Using Three-Factor Prothrombin Complex Concentrate in Patients with Major Bleeding Associated with Factor Xa Inhibitor

    T. Raksintham1, Y. Chinthammitr2, T. Ruchutrakool3, B. Suwannawiboon3

  • Abstract Number: PB2064

    Clinical Outcomes for Patients of High Body Weight on Apixaban or Rivaroxaban

    G. Bahra, Z. Mahir, V. Collings, K. Breen, B. Hunt, A. Cohen

  • Abstract Number: PB0600

    Clinical Performance of the Tina-Quant D-Dimer Gen 2 Assay on the Cobas t 711 Analyser for Evaluation of Patients with Suspected Deep Vein Thrombosis (DVT) and/or Pulmonary Embolism (PE)

    T. Bertsch1, S. Blaschke2, R. Body3, S. Davidson4, G. Guo5, D. Horner6, Y. Sun7, L. Turnes8, U. Sonner9, M. Hoffmann7

  • Abstract Number: PB1347

    Clinical Practise of SMOG System for Assessing Severity of Hemorrhagic Manifestations of Immume Thrombocytopenia (ITP) in Children

    D. Sigunova, L. Zhukova, K. Papayan, A. Morozova

  • Abstract Number: PB0388

    Clinical Presentation and Management of Homozygous Protein C Deficiency: Cukurova Experience

    N. Boz, H.I. Sasmaz, M. Cil, G. Leblebisatan

  • Abstract Number: PB2176

    Clinical Presentation and Outcomes of Cancer-associated Distal Deep Vein Thrombosis: Data from the RIETE Registry

    J.-P. Galanaud1, J. Trujillo-Santos2, B. Bikdeli3, V. Rosa4, A. Visona5, J.A. Nieto6, L. Mazzolai7, S. Soler8, M. Monreal9, RIETE Investigators

  • Abstract Number: PB1538

    Clinical Presentation of Von Willebrand Disease in a Developing Country-A Cross Sectional Study

    A. Fatima

  • Abstract Number: PB0872

    Clinical Review of Patients with Haemophilia (PwH) in a Malaysian Tertiary Center

    Y.L. Boo1, C.C.K. Liam1, K.Y. Yong1, R.J. Fann1,2, G.W.C. Lee1, G. Wilfred1, J. Sathar1

  • Abstract Number: PB0216

    Clinical Significance of T-cell Subsets for the Inhibitor Development in Pediatric Hemophilia A Patients

    Z. Chen, Z. Li, G. Li, Y. Zhen, K. Huang, R. Wu

  • Abstract Number: PB2317

    Clinical Spectrum and Prothrombotic Risk Factors of Cerebral Venous Sinus Thrombosis in Children

    Y. Düzenli Kar1, Z.C. Özdemir2, C. Yarar3, K.B. Çarman4, N. Tekin5, Ö. Bör2

  • Abstract Number: PB0309

    Clinical Study of Children’s Intracranial Hemorrhage in Single Hemophilia Center in China

    X. Feng1, H. Ge2

  • Abstract Number: PB1440

    Clinical Use of Carica Papaya Leaf Extract in Thrombocytopenia in Bernard-Soulier Syndrome

    O. El Safi1, M. Fathy1, S. Osama2, A. Osama3, S. Al Auch3

  • Abstract Number: PB0696

    Clinical Utilization of Lupus Anticoagulant Testing in a Large Hospital System

    A. Vijayanarayanan, R. Laforest, S. Philip, J. Hayward, I. Lopez-Plaza

  • Abstract Number: PB0996

    Clinical Validation of Population Pharmacokinetic Model for Plasma-Derived Factor VIII/VWF Comparing 3 Years Follow-up

    J.E. Megías-Vericat1, S. Bonanad2, S. Haya2, A.R. Cid2, M.R. Marqués3, E. Monte-Boquet3, S. Pérez-Alenda4, P. Bosch2, F. Querol4, J.L. Poveda3

  • Abstract Number: PB0575

    Clinical Validation of the T-TAS 01 PL Assay in Patients Taking Antiplatelet Therapy

    J. Dahlen1, P. Gurbel2, A.H.B. Wu3, K. Bliden2, C.-M. Ong3, U. Tantry2, K. Hosokawa4

  • Abstract Number: PB0574

    Clinical Validation of the T-TAS 01 PL Assay in Patients with von Willebrand Disease and Glanzmann´s Thrombasthenia

    J. Dahlen1, S.R. Lentz2, A.H.B. Wu3, M. Fiore4, A. Leavitt3, P. Gurbel5, C.-M. Ong3, K. Bliden5, T. Peters2, U. Tantry5, K. Hosokawa6

  • Abstract Number: PB1438

    Clinical, Morphological and Functional Platelet Tests in Inherited Thrombocytopenia

    F. Gonçalves1, F. Vasconcelos2, E. Cruz3, M. Pereira3, M. Carmona4, S. Esteves5, I. Freitas6, M. Lima3, S. Morais3

  • Abstract Number: PB1557

    Clinically Relevant Differences between Two New Generation VWF: GPIbR Assays in a Patient with Acquired von Willebrand Syndrome – Case Report

    K. Mayger1,2, A. McCormick1,2, S. Austin2

  • Abstract Number: PB0689

    Clinically Significant Disagreement between Point-of-Care INR and Central Laboratory-assessed INR in Acute Stroke Patients

    E. Salazar, B. Castillo, J. Chen, C. Leveque

  • Abstract Number: PB1503

    Clinico-pathological Spectrum of GlanzmannThrombasthenia

    D. Chandra, R. Gupta, K. Rahman, M. Singh, S. Nityanand

  • Abstract Number: PB0001

    Clopidogrel Resistance and P2y12 Receptor Gene Polymorphisms in Patients with Non-ST Elevated Acute Coronary Syndrome

    D. Shorikova1, E. Shorikov1, P. Shorikov2

  • Abstract Number: PB0458

    Clot Contraction Drives Structural Redistribution of Platelets, Fibrin and Red Blood Cells through Active Cell Sorting

    V. Tutwiler1, X. Chen2, R. Litvinov1,3, R. Khismatullin4, J. Weisel1, V. Shenoy2

  • Abstract Number: PB0018

    Clot Formation, Ultrastructure and Lysis in Patients with Acute Phase Myocardial Infarction

    S.R. Baker1,2, A. Siniarski3,4, C. Duval2, G. Gajos3,4, J. Nessler3, R.A.S. Ariens2

  • Abstract Number: OC 06.3

    Clotting Promotes Glioblastoma Progression

    L.M. Knowles1, C. Wolter1, R. Ketter2, S. Urbschat2, S. Linsler2, S. Müller2, A. Müller3, H. Eichler1, J. Pilch1

  • Abstract Number: PB1286

    Coagulation Activation Via Extrinsic Pathway Is the Major Cause of Hypercoagulation in Newborns during First Days of Life

    E. Koltsova1,2, E. Lipets1,2, B. Arutunyan3, N. Tetruashvili3, E. Balashova3, A. Karavaeva3, A. Balandina1,2

  • Abstract Number: PB0789

    Coagulation and Inflammation Genes Are Differently Expressed during the Acquired Coagulation Disorder Induced by Snake Envenomation

    A.T.A. Sachetto1, J.R. Jensen2, M.L. Santoro1

  • Abstract Number: PB0250

    Coagulation Assays Based on Surface-Mimicking Antibodies against Factor XII

    M. Heestermans1, C. Naudin2, K. Klaetschke1, C. Deppermann1, G. Pula1, L.M. Butler2, E.X. Stavrou3,4, T. Renné1

  • Abstract Number: PB0415

    Coagulation Factor IIIa (f3a) Knockdown in Zebrafish Leads to Defective Angiogenesis and Bleeding Phenotype

    S. Subramaniam1,2, S. Eisa-Beygi3, R. Ramachandran4, C. Fletcher2, H. Weiler1

  • Abstract Number: PB0413

    Coagulation Factor Xa [(Recombinant) Andexxa®] for Reversal of Apixaban and Rivaroxaban in Patients Diagnosed with Intracranial Hemorrhage

    M. Vestal1, K. Hodulik1, J. Mando-Vandrick1, M. Friedland2, T. Ortel3, I. Welsby2

  • Abstract Number: PB1790

    Coagulation Factor XII Binds to the Opportunistic Pathogen, Candida albicans and Promotes Biofilm Formation

    M.L. Williams1, D.S. Childers1, A.C. Brand2, N.J. Mutch1

  • Abstract Number: PB1776

    Coagulation Factor XII Signaling Triggers Inflammasome-associated Renal Damage in Diabetic Nephropathy

    A. Elwakiel1, K. Shahzad1, R. Rana1, D. Gupta1, I. Gadi1, S. Kohli1, T. Renné2, B. Isermann1

  • Abstract Number: PB1778

    Coagulation Markers, Neutrophil Extracellular Traps and Thrombin Generation Test, in the Detection and Risk Stratification of Prostate Cancer

    J. Oto1, Á. Fernández-Pardo1, E. Plana1, A. Cañada2, F. Cana1, M. Martínez-Sarmiento3, C.D. Vera-Donoso3, F. España1, P. Medina1

  • Abstract Number: PB1788

    Coagulation Profile in Patients with Pneumonia Assessed by Thrombin Generation Procedures

    E. Scalambrino1, M. Clerici1, S. Rossi2, V. Chantarangkul1, V. Monzani2, F. Peyvadi1,3, A. Tripodi1

  • Abstract Number: PB0283

    Coagulation Research in Paediatric ECMO: Delayed Consent to Improve Enrolment

    S. Van Den Helm1, J.G.F. Drop2,3, E.W. Wildschut3, R. Barton1,4,5, H.P. Yaw1,4, N. Letunica1, F. Newall1,4,5, A. Johansen6,7, D. Best6,7, J. McKittrick6, G. MacLaren1,6,8, R. Chiletti6,7, W. Butt4,6,7, Y. d'Udekem4,9, C.H. van Ommen2, V. Ignjatovic1,4, P. Monagle1,4,5

  • Abstract Number: PB0285

    Coagulation Research in Paediatric ECMO: The Need for a Common Languagecoagulation Research in Paediatric ECMO: The Need for a Common Language

    J. Drop1,2, S. Van Den Helm3, E. Wildschut2, R. Barton3,4,5, H.P. Yaw3,4, N. Letunica3, F. Newall3,4,5, A. Johansen6,7, D. Best6,7, J. McKittrick6, G. MacLaren3,6,8, S. Horton4,9, R. Chiletti6,7, W. Butt4,6,7, Y. d'Udekem4,9, C. van Ommen1, V. Ignjatovic3,4, P. Monagle3,4,5

  • Abstract Number: PB0800

    Coagulopathy in Pediatric Patients with Hemophagocytic Lymphohistiocytosis

    M. Shamoun1, K. Walkovich2, A. Weyand2

  • Abstract Number: PB1909

    Cohort of Patients with Triple Antiphospholipid Antibodies: Differences between Asymptomatic and Symptomatic Individuals

    P. Casais1,2, J. Salviú2, S. Meschengieser2

  • Abstract Number: PB0944

    Coinfection by Hepatitis B, C and HIV in Patients with Haemophilia

    D. O W Rodrigues1, O. F Santos2, T. S Esposito3, T. M M Paz4, J. D Rezende4, A. C A Santos4, L. O W Rodrigues5

  • Abstract Number: PB1625

    Cold over Room Temperature Storage of Apheresis Platelets Better Preserves Hemostatic Function out to 21 Days

    S.M. Shea, K.A. Thomas, P.C. Spinella

  • Abstract Number: PB1832

    Cold Storage of Apheresis Platelets Promotes IL-8 Release in Platelet: Leukocyte Co-cultures

    K.A. Thomas, S.M. Shea, P.C. Spinella

  • Abstract Number: PB1182

    Collagen Turnover and Plasma Ascorbic Acid Levels in Patients Suspected of Inherited Bleeding Disorders Harboring Variants in Collagen-related Genes

    M. Fager Ferrari1, E. Zetterberg1, M. Rossing2, T. Manon-Jensen3, M. Pehrsson3, M. Karsdal3, J. Lykkesfeldt4, E. Leinoe5

  • Abstract Number: PB1650

    Collagen-Induced Thrombocyte Aggregation in Essential Arterial Hypertension with Subclinical Organ Damage

    D. Shorikova1, E. Shorikov1, P. Shorikov2, O. Khukhlina1

  • Abstract Number: PB1959

    Colonization with the Minimal Microbial Consortium Altered Schaedler Flora Hampers the Formation of Neutrophil Extracellular Traps in Acute Mesenteric Ischemia-Reperfusion Injury

    F. Bayer1, S. Ascher1, F. Sommer2, C. Reinhardt1

  • Abstract Number: OC 13.3

    Combination of New Homozygous MPIG6B and SH2B3 Variants Leads to Early Onset Myelofibrosis, Thrombocytopenia and Abnormal Platelet Function

    M.-C. Morel-Kopp1,2, M. Levade1, Q. Chen1,2, A. Livings2, J. Curtin3, Y. Zhu4, C. Ward1,2, W. Stevenson1,2

  • Abstract Number: PB0220

    Combined Analysis of Dendritic Cell (DC) HLA-class-II (HLAcII) Peptidomic Profiling Data Derived from Different Therapeutic Factor VIII Proteins (tFVIIIs) in Independent Experiments/Laboratories

    V.P. Diego1,2, B.W. Luu1,2,3, M. Hofmann4, M. Almeida1,2, M.A. Gaytan1,2, H. Mead5, J.S. Powell6, R. Rajalingam7, J.M. Peralta1,2, S. Kumar1,2, J.E. Curran1,2, M.A. Escobar8, S. Williams-Blangero1,2, E. Maraskovsky9, J. Blangero1,2, T.E. Howard2,3,10

  • Abstract Number: PB1191

    Combined Factor Deficiencies Rare among the Rare Bleeding Disorders among Pediatric Population, Seven Years Experience in a Tertiary Care Center of Lahore, Pakistan

    T. Fateen, N. Mazhar, N. Saqlain, N. Ahmed

  • Abstract Number: PB1106

    Combined Gene and Cell Therapy for the Treatment of Hemophilia A within an Implantable Therapeutic Device

    C. Olgasi1, S. Merlin1, C. Borsotti1, A. Cucci1, T. Bergmann2, P. Bittorf2, K. Patterson3, D.M. Mazzuca3, A. Stolzing4, M. Zierau5, P.M. Toleikis3, F. Benedicenti6, A. Calabria6, E. Montini6, J. Braspenning2, A. Follenzi1

  • Abstract Number: PB1597

    Combined α4a- and β1-Tubulin Deficiencies Profoundly Affect Platelet Biogenesis and Haemostasis

    Q. Kimmerlin1, S. Moog1, A. Yakusheva1,2, A. Eckly1, C. Gachet1, P. Mangin1, C. Strassel1, F. Lanza1

  • Abstract Number: PB0968

    Comorbidities in Patients with Severe Haemophilia: Birth Cohort Analysis of Taiwan Society of Thrombosis and Hemostasis Database

    J.-D. Wang1,2, C.-Y. Lin2, T.-F. Weng2, S.-S. Chiou2, C.-T. Peng2, M.-C. Shen2

  • Abstract Number: PB1021

    Comorbidities of Hemophilia & Factor XIII Deficiency Patients

    M. Naderi1, F. Malek2

  • Abstract Number: PB0324

    Comparative Analysis of the Coagulometric and Chromogenic Methods for the Determination of Factor VIII Activity in the Plasma of Patients Suspected with Blood Coagulation Disorders

    E. Wojtasinska, J. Rupa-Matysek, P. Dziatkiewicz-Warkocz, M. Kozlowska-Skrzypczak, L. Gil

  • Abstract Number: PB1208

    Comparative Analysis of Three Custom Gene Panels Based on Next Generation Sequencing for Diagnostic of Inherited Coagulation Bleeding Disorders

    N. Borràs1, I. Corrales2, L. Ramírez2, N. Comes2, F. Vidal3

  • Abstract Number: PB0563

    Comparative Evaluation of the Aggregation Studies in a Sysmex CS2500 Coagulometer with a Standard Turbidimetric Technique

    A. Ramos, M. Pino, P. Molina, A.B. Moreno Castaño, M. Díaz-Ricart, G. Escolar

  • Abstract Number: PB0319

    Comparative Pharmacokinetics of Two Recombinant FVIII Concentrates in Chinese Pediatric Patients with Severe Hemophilia A: A Single-Center Study

    K. Huang, R. Wu, Z. Chen, Y. Zhen, X. Wu, G. Li

  • Abstract Number: PB2268

    Comparative Study between Thromboelastography and Conventional Coagulation Tests in Deep Vein Thrombosis

    B. Yan, W. Du, T. Hu

  • Abstract Number: PB2506

    Comparative Study of the Clinical Application of Two Bleeding Grading Systems for Pregnant Women with Immune Thrombocytopenia (ITP)

    M.J. Huang, J. Huang, B. Zeng, P. Chen, R. Zhan

  • Abstract Number: PB0051

    Comparison and Association of Fibrinogen, von Willibrand Factor and Factor VIII Levels with Risk of Cardiovascular Disease in Cigarette Smokers Residing in Calabar Metropolis, Nigeria

    D.C. Okpokam1, J.I. Asuquo2, J.O. Akpotuzor1

  • Abstract Number: PB1254

    Comparison between Bleeding Time and PFA-200 to Evaluate Platelet Function Disorder in Children

    C. Srichumpuang, D. Sosothikul

  • Abstract Number: PB0725

    Comparison Natural History and Genotype of 31 Patients with Inherited Dysfibrinogenemia

    T. Simurda1, J. Zolkova1, I. Skornova1, M. Brunclikova1, Z. Kolkova2, D. Loderer2, M. Dobrotova1, J. Ivankova1, M. Grendar2, Z. Lasabova3, J. Stasko1, P. Kubisz1

  • Abstract Number: PB0289

    Comparison of a New Point-of-Care Hemostasis Analyzer with Laboratory Parameters in Patients with Veno-venous Extracorporeal Membrane Oxygenation

    M. Lejeune1, P. Masi1, C. Desnos1, M. Pinton De Chambrun1, J. Chommeloux1, I. Martin-Toutain1, G. Nguyen1, A. Nieszkowska1, N. Bréchot1, M. Schmidt1, C.-E. Luyt1, I. Lefèvre2, A. Combes1, G. Hekimian1, C. Frere1,3

  • Abstract Number: PB0546

    Comparison of a Novel Viscoelastic Device with Standard Laboratory Tests for its Clinical Validation in Peri-Operative Cardiac Patients

    B. Brannan1,2, P. Govender1, S. Scheuermann1, S. Macdonald2, F. Falter3, M. Besser2,3

  • Abstract Number: PB0165

    Comparison of a Validated UHPLC-MS/MS Method and Chromogenic Anti-Xa Assays from Different Manufacturer for the Assessment of Edoxaban and its M4 Metabolite Levels in Plasma

    R. Siriez1, C. Bouvy2, J.-M. Dogné1,3, M. Hardy4,5, P. Hainaut6, J. Laloy3,7, F. Mullier4, H. Yildiz6, J. Douxfils1,2

  • Abstract Number: PB1528

    Comparison of an Automated von Willebrand Factor Activity Assay by HemosIL Werfen® with Ristocetin Cofactor Assay by Aggregometry in Thrombocytic Patients with Myeloproliferative Neoplasms or Secondary Thrombocytosis

    P. Laporte1, M. Tuffigo2, A. Ryman1, O. Mansier1,3, M. Fiore1, C. James1,3

  • Abstract Number: PB0970

    Comparison of Bleeding Pattern and Inhibitor Development among Hemophilia Patients: Prophylactic versus On-Demand Treatment

    G. Wilfred, V. Selvaratnam, Y.Y. Yap, J. Sathar

  • Abstract Number: PB1148

    Comparison of Bypassing Agents in Patients on Emicizumab Using Global Hemostasis Assays

    H. Kizilocak1, E. Marquez-Casas1, J. Malvar1, R. Carmona1, G. Young1,2

  • Abstract Number: PB1418

    Comparison of Clinical Adverse Events during Empiric Therapy for Patients with Suspected HIT

    K. Dykes1, C. Johnson2, J. Gong3, S.E. McKenzie4, H. Husseinzadeh4

  • Abstract Number: PB1118

    Comparison of Coagulation Parameters Associated with Fibrinogen Concentrate and Cryoprecipitate for Treatment of Bleeding in Patients Undergoing Cytoreductive Surgery for Pseudomyxoma Peritonei: Results from the FORMA-05 Study

    A. Roy1, N. Sargant1, C. Solomon2, I. Kruzhkova2, S. Knaub2, F. Mohamed1

  • Abstract Number: PB0637

    Comparison of Different Stago Instruments for Fibrinogen Level Assessment with STA-liquid Fib

    J.-B. Baudier1, L. Chaillet2, V. Genty2, A. Carlo3, S. Langlet1

  • Abstract Number: PB0898

    Comparison of FVIII Prophylaxis Treatment Regimen and Associated Clinical Outcomes between rVIII-SingleChain and Other rFVIII Products Commonly Used in Italian Hemophilia A Patients

    M.E. Mancuso1, C. Santoro2, G. Maro3, V. Rives4, P. Sommerer5

  • Abstract Number: PB0203

    Comparison of Medication Adherence Between Different Oral Anticoagulants: A Propensity Weighted Nationwide Cohort Study

    A.B. Ingason1,2, J.P. Hreinsson3, A.S. Agustsson1,2, S.H. Lund4, I.E. Reynisson5, B.R. Gudmundsdottir6, P.T. Onundarson1,6, E.S. Bjornsson1,2

  • Abstract Number: PB0543

    Comparison of New Scoring System of Platelet Aggregation on Automated Coagulation Analyzer CN-6000 with CS-5100

    M. Egashira1, K. Kitano1, R. Narisada2, M. Kono3, K. Nakajima3, T. Sakayori1

  • Abstract Number: PB1395

    Comparison of Platelet Function Testing in Patients Undergoing Neuroradiological Flow Diversion Stents

    M. Gergi1, R. McTaggart2, T. Cheves3, J. Sweeney4

  • Abstract Number: PB1798

    Comparison of Platelet Parameters in the Patients with JAK2 V617F Mutated Essential Thrombocytosis and Reactive Thrombocytosis

    Y. Wu1,2, M. Gu3, S. Lin3, W. Huang1, T. Wang1,2, S. Chu1,2

  • Abstract Number: OC 11.2

    Comparison of Recommended Postpartum Thromboprophylaxis and of Absolute Risk Thresholds According to the RCOG, ACCP and ACOG Guidelines

    N. Gassmann1, M. Viviano2, P. Fontana3, M. Righini3, B. Martinez De Tejada2, M. Blondon3

  • Abstract Number: PB0520

    Comparison of the Biophen® Heparin LRT with the HemosIL® Liquid Anti-Xa Assay for the Measurement of Apixaban, Edoxaban and Rivaroxaban

    C. Bundschuh, M. Egger, K. Wiesinger, B. Dieplinger

  • Abstract Number: PB0594

    Comparison of the One-Stage Clot-Based and Chromogenic Factor VIII Activity Measurement

    R. Al Buraidi1, M. Al-Khabori2, K. Al Falahi2, B. Al Baloushi2, B. Al-Rawahi2, J. Mahlangu3, A. Pathare2

  • Abstract Number: PB0576

    Comparison of the T-TAS 01 PL Assay with PFA-100 for Assessment of Primary Hemostatic Function

    J. Dahlen1, P. Gurbel2, A.H.B. Wu3, S.R. Lentz4, M. Fiore5, A. Leavitt3, K. Bliden2, C.-M. Ong3, T. Peters4, U. Tantry2, K. Hosokawa6

  • Abstract Number: PB0664

    Comparison of Thromboelastography with T2MR Data

    M. Stolz1, M. Strauß2, S. Hammer1, I. Marini1, F. Schick3, T. Bakchoul1,2

  • Abstract Number: PB0698

    Comparison of Thromboelastometry by ROTEM® Delta and ROTEM® Sigma in Obese Patients

    C. Bulato1, E. Campello1, C.M. Radu1,2, L. Spiezia1, P. Simioni1

  • Abstract Number: PB0560

    Comparison of Two Quantitative Methods for Determination of Dabigatran Concentration: Diluted Thrombin Time Test and Innovance Dabigatran Test in Real Life Patients Treated with Dabigatran

    S. Šupraha-Goreta1, S. Margetić2, I. Ćelap2, R. Mihić3

  • Abstract Number: PB1364

    Comparison of Various Diagnostic Methods in Assessing Platelet Count in Patients with Immunotrombocytopenia

    M. Witkowski1, M. Witkowska2, M. Tybura-Sawicka3, A. Majchrzak1, J. Treliński3, K. Chojnowski3, T. Robak4, P. Smolewski2

  • Abstract Number: PB0590

    Comparison of Visual versus Reader Results of the Point of Care Test of Direct Oral Anticoagulants from Urine Samples

    J. Harenberg1, F. Loesel2, J. Douxfils3,4, I. Elalamy5,6, J. Beyer Westendorf7,8, R. Bauersachs9, P. Verhamme10, M. Crowther11, S. Hetjens12, C. Weiss12

  • Abstract Number: PB1580

    Comparison of von Willebrand Factor (VWF) Multimeric Profile Obtained by a Commercial Electrophoretic Test (Hydragel 5 von Willebrand Multimers) and Classical Home-made with a Discontinuous 1% Agarose Gel Electrophoresis

    M.S. López1,2, J. Paiva3, A.I. Woods4, M.S. Saez1,2, L.H. Barrera1,5, V. Privitera6, F. Chuliber6, M. Villagra Iturre6, D. Penchasky6, P. Sorroche1,2, J. Oyhamburu1,2, M. Martinuzzo1,2, A. Sánchez Luceros3,4

  • Abstract Number: PB1783

    Complement Mannan-Binding-Lectin Is Associated with Activated Platelets during Clot Formation in a Microfluidic Bleeding Model

    M. Golomingi1, L. Jenny1, E.T. Hardy2, W. Lam2, V. Schroeder1

  • Abstract Number: PB1945

    Complement Pathway and Endothelial Dysfunction in Severe Preeclampsia

    M. Palomo1, M. Blasco2, F. Crispi3, S. Torramade-Moix4, P. Molina4, J.M. Campistol2, J.C. Garcia Pagan5, E. Gratacos3, G. Escolar4, M. Diaz-Ricart4

  • Abstract Number: OC 05.5

    Complement Regulator Factor H is a Cofactor for Thrombin in both Pro- and Anticoagulant Roles

    G. McCluskey1, G. Davies1, R. Velounias1, T.R. Hughes2, B.P. Morgan2, R. Preston3, P.W. Collins2,4, P.V. Jenkins4, M. Heurich1

  • Abstract Number: PB1925

    Complement Regulatory Abnormalities are Frequent in Patients with Catastrophic APS and Refractory Patients Respond Rapidly to Eculizumab Treatment

    H. Liebman1, I. Weitz2

  • Abstract Number: PB1470

    Complex Changes in Plasma Associated with Platelet Dysfunction in Trauma Patients

    A. St. John1, J. Chen2, J. Le2, E. Lim1, S. Stern1, J. Lopez2, N. White1

  • Abstract Number: PB0450

    Comprehensive Platelet Phenotyping Supports the Role of Platelets in the Pathogenesis of Acute Venous Thromboembolism – Results from Clinical Observational Studies

    M. Panova-Noeva1,2, B. Wagner3, M. Nagler3, V. ten Cate3, J. Prochaska1,2,3, S. Heitmeier4, I. Meyer4, C. Gerdes4, V. Laux4, S. Konstantinides5, H. Spronk6, K. Lackner7, K. Leineweber4, H. ten Cate6, P. Wild1,2,3

  • Abstract Number: PB2451

    Concentration Levels of Direct Oral Anticoagulants and Clinical Relevance in a Tertiary Hospital

    F. Martins Pereira1, I. Machado2, A.P. Teixeira2, L. Ricca Gonçalves2, M. Carvalho2, C. Koch2

  • Abstract Number: PB0819

    Concizumab Does Not Affect Activated Partial Thromboplastin Time, Prothrombin Time or Factor VIII/IX Activity Measured Using One-Stage Clotting or Chromogenic Substrate Assays

    M. Kjalke, M. Kjelgaard-Hansen, I. Hilden

  • Abstract Number: PB2085

    Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation

    M. Giustozzi1, M. Mazzetti2, M. Paciaroni1, G. Agnelli1, C. Becattini1, M.C. Vedovati1

  • Abstract Number: PB1198

    Congenital Afibrinogenemia. Report of a Case in the Children´S Hospital of Mexico Federico Gomez

    J.F. Mariano González1, A.M. Moreno González2

  • Abstract Number: PB1190

    Congenital Combined Bleeding Disorders, a Study on a Large Number of Iranian Patients

    M.R. Baghaipour1, S. Tabibian1,2, F. Ala1, M. Jazebi1, G.R. Bahoush1,3, S.E. Ahmadi2, N. Baghaipour4

  • Abstract Number: PB0190

    Congenital Factor X Deficiency with Isolated Prothrombin Time Prolongation

    D. Gurlek Gokcebay1, D. Kacar1, S. Sahin1, N. Yarali1, N.Y. Ozbek1, A. Girolami2

  • Abstract Number: PB0719

    Congenital Qualitative Fibrinogen Disorders: Case Series from Argentina; Multicentric Collaborative Study

    C.M. Rosa1, M. Neerman-Arbez2, C. Duboscq3, A. Vilaseca4, J. Ceresetto3, M.E. Aris Cancela5, P. Colimodio5, L. Barrera6,7, M.S. Lopez6,7, J.M. Oyhamburu6,7, V. Privitera8, E.S. Viñuales8, E. Nucifora8, M. Kalmus8, S. Meschengieser9, A. Casini10, P. de Moerloose11, M.E. Martinuzzo7,12

  • Abstract Number: PB1092

    Consistent Structural Kinetics of Valoctocogene Roxaparvovec DNA in Human Blood Samples

    C. Russell1, R. Torres1, K. Patton1, J. Holcomb1, M. Vora1, K. Obrochta1, A. van Tuyl1, B. Kim2, S. Zoog1, C. Vettermann1

  • Abstract Number: PB1117

    Continuous Infusion with Kovaltry (Octocog Alfa) during Cardiac Surgery for Tetralogy of Fallot in an Hemophilic Child

    A. Amoruso, G. Lassandro, V.V. Palmieri, V. Palladino, C. Pastore, P. Giordano

  • Abstract Number: PB1933

    Contribution of Beta2 Glycoprotein1 IgA (B2GP1 IgA) Antibodies Research in Diagnosis of Seronegative Antiphospholipid Syndrome in Cerebral Thrombosis: A Case Series of 21 Patients

    I. Hocine, Y. Ferhat-Hamida, G. Hariti

  • Abstract Number: PB0007

    Contribution of Fibrin and von Willebrand Factor to Platelet Adhesion on Ruptured Atherosclerotic Plaque in Acute Myocardial Infarction

    A. Yamashita1, K. Nishihira2, K. Maekawa1, T. Gi1, S. Horiuchi1, K. Hatakeyama3, Y. Shibata2, Y. Asada1

  • Abstract Number: PB0815

    Contributions of the Individual Components of an Activated Prothrombin Complex Concentrate to Thrombin Generation in the Presence of Emicizumab

    D. Monroe1, M. Ezban2, M. Hoffman3,4

  • Abstract Number: PB2165

    Cooperation about the Treatment of the Venous Thromboembolism in Cancer Institute Hospitals and Neighboring Cooperation Acute Hospitals

    C. Yasuda1, T. Shiga2, K. Iwasa3, M. Shoji3, T. Takahashi4, Y. Nishihata5, K. Suzuki4

  • Abstract Number: PB0266

    Corn Trypsin Inhibitor in the Preanalytical Phase of Contact Activation Assays

    M.M. Engelen1,2, C. Vandenbriele1,2, P. Verhamme1,2, T. Vanassche1,2

  • Abstract Number: PB1143

    Correction of Human Hemophilia B Gene in iPSCs by Base-Editing Approach Based on Engineered Cas9 with Broad PAM Flexibility

    T. Hiramoto1, Y. Kashiwakura1, T. Abe2, N. Kamoshita1, M. Hayakawa1, H. Inaba3, T. Togashi1, H. Nishimasu4, Y. Hanazono2, O. Nureki4, T. Ohmori1

  • Abstract Number: PB0399

    Correlation between ADAMTS13 and VAP1 Levels in Multiple Sclerosis with Cerebral Microbleeds

    N. Ziliotto1, R. Zivadinov2,3, M. Baroni1, D. Jakimovski2, N. Bergsland2,4, D.P. Ramasamy2, B. Weinstock-Guttman5, M. Ramanathan6, G. Marchetti7, F. Bernardi1

  • Abstract Number: PB2475

    Correlation between Anti-Xa Activity and Plasmatic Levels of Apixaban

    D. Velasco1, R. Vidal2, A. Garcia Raso3, S. Martin3, P. Llamas3

  • Abstract Number: PB0617

    Correlation between INR Pocket Test and Standard Coagulation Test

    A.B. Vilaseca1, N.M. Mato1, R.F. Barbera2, G. Begue1, C. Capmany1, N. Kujta1, E.M. Romero1, P. Sebastian1, C.C. D´antonio1

  • Abstract Number: PB2326

    Correlation between Intrinsic D-Dimer Levels and D-Dimer Measured at First Venous Thromboembolism (VTE)

    F.B. Rinde1, E.-S. Hansen1, V. Morelli1, J.-B. Hansen1,2, S.K. Brækkan1,2

  • Abstract Number: PB1884

    Correlation between Phenotype-genotype versus in-silico Prediction of Novel and Known Disease-causing Variants in Upshaw-Schulman Syndrome Patients in a Single Institution of Argentina

    J. Paiva1, A.I. Woods2, A. Kinen1, M.M. Casinelli1, A. Sanchez-Luceros1,2

  • Abstract Number: PB0384

    Correlation between Protein C and CCL18 Levels in Multiple Sclerosis

    N. Ziliotto1, R. Zivadinov2,3, M. Baroni1, D. Jakimovski2, N. Bergsland2,4, D.P. Ramasamy2, B. Weinstock-Guttman5, M. Ramanathan6, G. Marchetti7, F. Bernardi1

  • Abstract Number: PB0540

    Correlation between the VerifyNow P2Y12 Assay and the Newly-Developed APAL System in Neuroendovascular Patients

    K. Uematsu1,2, T. Sakayori3, H. Ishida4, Y. Omori4, K. Kitano3, H. Matsubara2, Y. Enomoto2

  • Abstract Number: PB0578

    Correlation between Thrombin Generation and Prothrombin Fragment F1+2 Plasma Levels

    M. Capecchi1,2, E. Scalambrino1, S. Griffini1, E. Grovetti1,3, M. Clerici1, G. Merati1, V. Chantarangkul1,3, M. Cugno1,3,4, F. Peyvandi1,3,4, A. Tripodi1,3

  • Abstract Number: PB1498

    Correlation GLATIT Scores and the Number of Bleeding Episodes in the Assessment of the Prognosis of Inherited Platelet Disorder

    R. Messaoudi, D.Saidi, H.Touhami

  • Abstract Number: PB0003

    Correlation of D-Dimer Levels with Troponin I in Patients with Acute Myocardial Infarction

    M. Ismail

  • Abstract Number: PB2473

    Correlation of Reperfusion Therapy and In-hospital Mortality in Patients with Intermediate Risk Acute Pulmonary Embolism and Right Ventricular Dysfunction

    J. Bilbao1, J. Bonorino1, F. Horacio1, C. Ferrario2, N. Torres1, M. Iwanowski1, R. Melchiori1, P. Alarcon1, J. Santucci1, M. Conde Blanco2, E. Ortis1, M.E. Aris Cancela3, R. Della Cella1, S. Krause1, A. Sanchez1, N. Perez Caceres1, S. Marquez1, P. Rubio1, A. Hita1, S. Baratta1

  • Abstract Number: PB1406

    Correlation of VASP Phosphorylation Assay with Light Transmission Aggregometry for Patients Treated with Clopidogrel or Ticagrelor

    C. Pons1, M. Moulard1, M. Canault2, M. Ibrahim2, M.-C. Alessi2

  • Abstract Number: PB1048

    Correlations of Von Willebrand Factor Levels, Factor VIII (FVIII) Pharmacokinetics and Prophylaxis Dose in Severe Haemophilia A Patients Switching to rFVIII-Fc Studied by Individual and Population Tool-assisted PK Assessments

    A. Coppola1, G. Quintavalle1, G.F. Rivolta1, F. Riccardi1, A. Matichecchia1, A. Benegiamo2, R.D. Ruenes2, F.L. Dallari2, R. Rossi2, A. Tagliaferri1

  • Abstract Number: PB1378

    Corticosteroid Reduction or Discontinuation after Initiation of Avatrombopag Treatment in Patients with Chronic Immune Thrombocytopenia (ITP)

    M. Recht1,2, A. Dixon3, K. Aggarwal3, M. Vredenburg3

  • Abstract Number: PB2284

    Cost-Effectiveness of Magnetic Resonance Direct Thrombus Imaging for Diagnosing Recurrent Ipsilateral Deep Vein Thrombosis

    L.F. van Dam1, W.B. van den Hout2, G. Gautam3, C.E.A. Dronkers1,4, Å. Eckerbom3, W. Ghanima5,6, J. Gleditsch7, A. von Heijne3, H.M.A. Hofstee4, M.M.C. Hovens8, M.V. Huisman1, A.T.A. Mairuhu9, M. Nijkeuter10, M.A. van de Ree11, C.J. van Rooden12, R.E. Westerbeek13, J. Westerink10, E. Westerlund3, L.J.M. Kroft14, F.A. Klok1

  • Abstract Number: PB0768

    Covalent Prourokinase-dendrimer Complexes with Increased Plasma Stability and High Thrombolytic Activity in vitro

    E. Ivanova1, L. Mukhametova1,2, R. Aisina1, K. Gershkovich3

  • Abstract Number: PB/CO21

    COVID-19 Pandemic: Dissecting Coagulation apart from Inflammation

    J. Gonzalez-Lugo1, S. Rahman1, M. Barouqa2, J. Szymanski2, H. Billett1, M. Reyes Gil2

  • Abstract Number: PB0141

    CRISPR/Cas9-Mediated Generation of a RUNX1 Knock-In Mice Model and Platelet Characterization

    A. Marín-Quílez1, R. Benito1, I. García-Tuñón1, C. Fernández-Infante1, L. Hernández-Cano1, A. Vega-Marín1, L. Méndez-Sánchez2, M. del Rey1, J.L. Ordoñez1, V. Palma-Barqueros3, M.L. Lozano3, M. Sánchez-Martín1,2, C. Guerrero1, J.R. González Porras4, J. Rivera3, J.M. Hernández-Rivas1,4, J.M. Bastida4

  • Abstract Number: PB1844

    Critical Role for Platelet Ral GTPases in the Regulation of Venous Thrombosis

    Y. Li, C. Williams, B. Amulic, A. Poole

  • Abstract Number: PB1843

    Critical Role of Platelets during Pulmonary Fibrosis

    R. Martos1, I. Machkour1, R. Chalghoumi1, K. Yahiaoui1, H. Lebas1, W. Bergemeier2, B. Nieswandt3, V. Arocas1, M.-C. Bouton1, Y. Boulaftali1

  • Abstract Number: PB0470

    Cross-sectional Study of Thrombin Generation and Overall Hemostatic Potential in a Cohort Clinically Investigated for Thrombophilia

    M. Farm1,2, D.E. Schmidt3,4, Y. Zong1, N. Soutari1,2, A. Antovic5,6, I. Pruner1, J.P. Antovic1,2, N. Bark2

  • Abstract Number: PB1768

    Cross-Talk of Activated Protein C(aPC) with Integrin and its Effect on T-Cell Signaling

    D. Gupta1, S. Ranjan1, A. Elwakiel1, A. Müller2, R. Rana1, S. Kohli1, B. Isermann1

  • Abstract Number: PB0056

    Crosstalk between Platelet and Endothelial Dysfunction in Survivors of Allogeneic Hematopoietic Cell Transplantation Independently of Traditional Cardiovascular Risk Assessment

    E. Gavriilaki1,2, E. Gkaliagkousi2, I. Sakellari1, I. Batsis1, A. Vardi1, A. Lazaridis2, P. Anyfanti2, B. Nikolaidou1, I. Zarifis2, M. Masmanidou1, E. Yiannaki3, D. Markala3, S. Douma2, A. Anagnostopoulos1

  • Abstract Number: PB1953

    CTL-2 is a VWF Receptor Involved in Neutrophil Activation

    G. Zirka1, P. Robert2,3, J. Tilburg4, C. Maracle4, P. Legendre5, M.C. Alessi1,6, P.J. Lenting5, P.E. Morange1,7, G.M. Thomas1

  • Abstract Number: PB0912

    Current Challenges in Diagnosis and Management of Hemophilia Afghanistan

    S.H. Mousavi1,2, S.A. Mesbah-Namin3, M. Jazebi4, A. Dorgalaeh5, S. Zeinali6,7

  • Abstract Number: PB1513

    Current Data About Arterial Thrombotic Events in Cerebrovascular Circulation Caused by Sticky Platelet Syndrome in the National Registry of Thrombophilic States in Slovak Republic

    M. Brunclikova1, L. Stanciakova2, J. Ivankova2, M. Skerenova3, M. Dobrotova2, P. Holly2, T. Simurda2, P. Kubisz2, J. Stasko2

  • Abstract Number: PB1864

    Current Possibilities of ADAMTS 13 Diagnostics – Advantages and Limitations

    P. Bradacova1, L. Slavik2, J. Ulehlova2, J. Prochazkova2, A. Hlusi2, K. Chasakova3

  • Abstract Number: PB2135

    Current Status on Non-hematological Cancer Associated Thrombosis at Tertiary Care Hospital in India

    M. Aggarwal1, A. Ramaswami2,3, M. Mahapatra2

  • Abstract Number: PB2007

    Cytokine Network Architecture at the Endothelial Interface

    A.J. Hoogendijk1, E.F.J. Janssen1, B.L. van den Eshof1, F.P.J. van Alphen1, C. van der Zwaan1, A.B. Meijer1,2, M. van den Biggelaar1

Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley